Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses
/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2009-02-03 / Cancer Res. 2009 Feb;69(4):1448-58The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer
/in International Publications, Newcastle Disease Virus /von 2009-01-31 / Cancer Immunol. Immunother. 2009 Aug;58(8):1175-84Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice
/in International Publications, Newcastle Disease Virus /von 2009-01-28 / Liver Int. 2009 Apr;29(4):593-602Newcastle disease virus-induced cytopathic effect in infected cells is caused by apoptosis
/in International Publications, Newcastle Disease Virus /von 2009-01-17 / Virus Res. 2009 Apr;141(1):13-20Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2009-01-01 / Methods Mol. Biol. 2009;542:565-605Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2008-10-18 / Neurol. Res. 2009 Feb;31(1):3-10Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-10-01 / Int. J. Oncol. 2008 Oct;33(4):823-32Recombinant Newcastle disease virus as a vaccine vector for cancer therapy
/in International Publications, Newcastle Disease Virus /von 2008-08-19 / Mol. Ther. 2008 Nov;16(11):1883-90Virus combinations and chemotherapy for the treatment of human cancers
/in International Publications, Newcastle Disease Virus /von 2008-08-01 / Curr. Opin. Mol. Ther. 2008 Aug;10(4):371-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de